Eargo Inc (NAS:EAR)
$ 2.57 0 (0%) Market Cap: 53.36 Mil Enterprise Value: 14.99 Mil PE Ratio: 0 PB Ratio: 1.18 GF Score: 35/100

Eargo Inc at JPMorgan Healthcare Conference (Virtual) Transcript

Jan 12, 2021 / 07:00PM GMT
Release Date Price: $1078.4 (+5.11%)
Robert Justin Marcus
JPMorgan Chase & Co, Research Division - Analyst

Hello, everyone. Welcome back from the lunch break. I'm Robbie Marcus, I'm the medtech analyst at JPMorgan. I'm happy to introduce our next company. It's from the IPO class of 2020 Eargo, DTC hearing aid company. Happy to introduce Christian Gormsen, the CEO. But Christian, before I turn it over to you, quick housekeeping. You can grab the slides from the JPMorgan Healthcare website. You can also submit a question there, which I can do my best to get to in Q&A or feel free to e-mail me or chat me on Bloomberg. And like I said, I'll do my best to answer or ask all the questions.

So with that, Christian, I'm going to hand it over to you, and we'll join you for Q&A afterwards.

Christian Gormsen
Eargo, Inc. - CEO, President & Director

Great. Thank you, Robbie, and thank you, JPMorgan, for all of your support over this very exciting last year. So I'm very pleased to be here today. I'm Christian Gormsen, I'm the CEO of Eargo. And will we get the slides up and running as

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot